These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

667 related articles for article (PubMed ID: 33778374)

  • 1. Compassionate Use of Rectal Ozone (O
    Fernández-Cuadros ME; Albaladejo-Florín MJ; Álava-Rabasa S; Gallego-Galiana J; Pérez-Cruz GF; Usandizaga-Elio I; Pacios E; Torres-García DE; Peña-Lora D; Casique-Bocanegra L; López-Muñoz MJ; Rodríguez-de-Cía J; Pérez-Moro OS
    SN Compr Clin Med; 2021; 3(5):1185-1199. PubMed ID: 33778374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Rectal Ozone (O
    Fernández-Cuadros ME; Albaladejo-Florín MJ; Álava-Rabasa S; Usandizaga-Elio I; Martinez-Quintanilla Jimenez D; Peña-Lora D; Neira-Borrajo I; López-Muñoz MJ; Rodríguez-de-Cía J; Pérez-Moro OS
    SN Compr Clin Med; 2020; 2(9):1328-1336. PubMed ID: 32838181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sarilumab versus standard of care for the early treatment of COVID-19 pneumonia in hospitalized patients: SARTRE: a structured summary of a study protocol for a randomised controlled trial.
    Caballero Bermejo AF; Ruiz-Antorán B; Fernández Cruz A; Diago Sempere E; Callejas Díaz A; Múñez Rubio E; Avendaño-Solá C; Ramos Martínez A; Sancho López A;
    Trials; 2020 Sep; 21(1):794. PubMed ID: 32938496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retrospective Cohort Observational Study to compare the Effect of Mycobacterium w along with Standard of Care vs Standard of Care alone in critically ill COVID-19 Patients.
    Dixit S; Zirpe K; Suryawanshi P; Borawake K; Prasad S; Ambapkar S; Ambapkar S; Joshi A; Joshi M
    J Assoc Physicians India; 2022 Jul; 70(7):11-12. PubMed ID: 35833395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial.
    Payares-Herrera C; Martínez-Muñoz ME; Vallhonrat IL; de Molina RM; Torres MP; Trisan A; de Diego IS; Alonso R; Zafra R; Donaire T; Sánchez R; Rubio JJ; Duarte Palomino RF; Solá CA
    Trials; 2021 Jan; 22(1):9. PubMed ID: 33407777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative Survival Analysis of Immunomodulatory Therapy for Coronavirus Disease 2019 Cytokine Storm.
    Narain S; Stefanov DG; Chau AS; Weber AG; Marder G; Kaplan B; Malhotra P; Bloom O; Liu A; Lesser ML; Hajizadeh N;
    Chest; 2021 Mar; 159(3):933-948. PubMed ID: 33075378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose subcutaneous tocilizumab to prevent disease progression in patients with moderate COVID-19 pneumonia and hyperinflammation.
    Potere N; Di Nisio M; Rizzo G; La Vella M; Polilli E; Agostinone A; Spacone A; Di Carlo S; Costantini A; Abbate A; Porreca E; Parruti G
    Int J Infect Dis; 2020 Nov; 100():421-424. PubMed ID: 32768701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxygen-ozone (O
    Franzini M; Valdenassi L; Ricevuti G; Chirumbolo S; Depfenhart M; Bertossi D; Tirelli U
    Int Immunopharmacol; 2020 Nov; 88():106879. PubMed ID: 32795898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood ozonization in patients with mild to moderate COVID-19 pneumonia: a single centre experience.
    Tascini C; Sermann G; Pagotto A; Sozio E; De Carlo C; Giacinta A; Sbrana F; Ripoli A; Castaldo N; Merelli M; Cadeo B; Macor C; De Monte A
    Intern Emerg Med; 2021 Apr; 16(3):669-675. PubMed ID: 33131033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison between methylprednisolone infusion and dexamethasone in COVID-19 ARDS mechanically ventilated patients.
    Saeed MAM; Mohamed AH; Owaynat AH
    Egypt J Intern Med; 2022; 34(1):19. PubMed ID: 35194371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential therapeutic effect of oxygen-ozone in controlling of COVID-19 disease.
    Yousefi B; Banihashemian SZ; Feyzabadi ZK; Hasanpour S; Kokhaei P; Abdolshahi A; Emadi A; Eslami M
    Med Gas Res; 2022; 12(2):33-40. PubMed ID: 34677149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective, randomised, double blind placebo-controlled trial to evaluate the efficacy and safety of tocilizumab in patients with severe COVID-19 pneumonia (TOC-COVID): A structured summary of a study protocol for a randomised controlled trial.
    Rilinger J; Kern WV; Duerschmied D; Supady A; Bode C; Staudacher DL; Wengenmayer T
    Trials; 2020 Jun; 21(1):470. PubMed ID: 32493514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical effectiveness of medical ozone therapy in COVID-19: the evidence and gaps map.
    Serra MEG; Baeza-Noci J; Abdala CVM; Luvisotto MM; Bertol CD; Anzolin AP
    Med Gas Res; 2023; 13(4):172-180. PubMed ID: 37077114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy assessment of allogeneic human dental pulp stem cells to treat patients with severe COVID-19: structured summary of a study protocol for a randomized controlled trial (Phase I / II).
    Ye Q; Wang H; Xia X; Zhou C; Liu Z; Xia ZE; Zhang Z; Zhao Y; Yehenala J; Wang S; Zhou G; Hu K; Wu B; Wu CT; Wang S; He Y
    Trials; 2020 Jun; 21(1):520. PubMed ID: 32532356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ozone as an adjuvant therapy for COVID-19: A systematic review and meta-analysis.
    Setyo Budi D; Fahmi Rofananda I; Reza Pratama N; Sutanto H; Sukma Hariftyani A; Ratna Desita S; Zinedinita Rahmasari A; Pudy Asmarawati T; Agung Waskito L; Dyah Kencono Wungu C
    Int Immunopharmacol; 2022 Sep; 110():109014. PubMed ID: 35803132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized open-label trial to evaluate the efficacy and safety of triple therapy with aspirin, atorvastatin, and nicorandil in hospitalised patients with SARS Cov-2 infection: A structured summary of a study protocol for a randomized controlled trial.
    Sharma A; Sharma C; Raina S; Singh B; Dadhwal DS; Dogra V; Gupta S; Bhandari S; Sood V
    Trials; 2021 Jul; 22(1):451. PubMed ID: 34266452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective, randomized, controlled study assessing vagus nerve stimulation using the gammaCore®-Sapphire device for patients with moderate to severe CoViD-19 Respiratory Symptoms (SAVIOR): A structured summary of a study protocol for a randomised controlled trial".
    Tornero C; Vallejo R; Cedeño D; Orduña J; Pastor E; Belaouchi M; Escamilla B; Laredo M; Del Mar Garzando M
    Trials; 2020 Jun; 21(1):576. PubMed ID: 32586395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of ozone therapy in mild to moderate COVID-19 patients: A phase 1/11 randomized control trial (SEOT study).
    Shah M; Captain J; Vaidya V; Kulkarni A; Valsangkar K; Nair PMK; Ganu G
    Int Immunopharmacol; 2021 Feb; 91():107301. PubMed ID: 33421928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the efficacy and safety of recombinant erythropoietin on the improvement of hospitalised COVID-19 patients: A structured summary of a study protocol for a randomised controlled trial.
    Samimagham HR; Azad MH; Hooshyar D; Haddad M; Arabi M; KazemiJahromi M
    Trials; 2021 Jul; 22(1):435. PubMed ID: 34229729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.